Fulcrum Therapeutics, Inc. (FULC)
3.86
+0.02
(+0.52%)
USD |
NASDAQ |
Aug 25, 16:00
3.83
-0.03
(-0.78%)
After-Hours: 19:59
Fulcrum Therapeutics Total Assets (Quarterly) : 323.95M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 323.95M |
| March 31, 2026 | 346.77M |
| December 31, 2025 | 366.28M |
| September 30, 2025 | 214.86M |
| June 30, 2025 | 228.84M |
| March 31, 2025 | 242.65M |
| December 31, 2024 | 260.72M |
| September 30, 2024 | 279.01M |
| June 30, 2024 | 294.26M |
| March 31, 2024 | 232.59M |
| December 31, 2023 | 257.69M |
| September 30, 2023 | 278.88M |
| June 30, 2023 | 300.33M |
| March 31, 2023 | 321.12M |
| December 31, 2022 | 226.68M |
| September 30, 2022 | 247.80M |
| Date | Value |
|---|---|
| June 30, 2022 | 195.23M |
| March 31, 2022 | 220.25M |
| December 31, 2021 | 235.00M |
| September 30, 2021 | 255.55M |
| June 30, 2021 | 137.88M |
| March 31, 2021 | 156.48M |
| December 31, 2020 | 129.58M |
| September 30, 2020 | 142.22M |
| June 30, 2020 | 144.86M |
| March 31, 2020 | 94.86M |
| December 31, 2019 | 110.44M |
| September 30, 2019 | 115.96M |
| June 30, 2019 | 65.15M |
| March 31, 2019 | 75.59M |
| December 31, 2018 | 85.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Definium Therapeutics, Inc. | 1.113B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.26M |
| Shareholders Equity (Quarterly) | 310.70M |
| Debt to Equity Ratio | 0.017 |
| Current Ratio | 31.35 |
| Net Debt Paydown Yield | 0.20% |